Longitudinal Associations Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Cardiovascular Measures in Chinese Children.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 39787371.
- Also identified by DOI 10.14309/ajg.0000000000003278.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The clinical utility of metabolic dysfunction-associated steatotic liver disease (MASLD) in predicting subsequent subclinical cardiovascular damages in pediatric population remains poorly understood. Data on 1,161 Chinese children aged 10-15 years were used to assess the longitudinal associations of MASLD with subsequent subclinical cardiovascular measures. Compared with relatively healthy children, children with MASLD had abnormal vascular and cardiac structures, along with reduced cardiac diastolic function at the 2-year follow-up. In addition, children with MASLD had a significantly increased risk of high carotid intima-media thickness and left ventricular hypertrophy. These findings support the clinical utility of MASLD in predicting the development of subclinical cardiovascular damages in childhood.
Medical subject headings
- Fatty Liver
- Hypertrophy, Left Ventricular
- Cardiovascular Diseases